96-28266. National Cancer Institute; Notice of Meeting

[Federal Register Volume 61, Number 214 (Monday, November 4, 1996)]
[Notices]
[Page 56698]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28266]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Meeting

    Notice is hereby given of the meeting of the National Cancer 
Institute Board of Scientific Advisors Clinical Trials Review Working 
Group, November 25-26, 1996 at the Doubletree Hotel, Rockville, 
Maryland.
    The meeting will be open to the public on November 25, 1996 from 8 
am to 2 pm for discussions of methods to maximize the exchange of 
information and collaboration between laboratory and clinical 
scientists and between the pharmaceutical industry and NCI funded 
researchers, and on November 26 from 8 am to 8:30 am for introductory 
remarks and welcome.
    The meeting will be closed to the public on November 25, 1996 from 
2 pm to approximately 6 pm and on November 26 from 8:30 am to 
approximately 6 pm for discussion of confidential issues relating to 
the review, discussion and evaluation of individual programs and 
projects conducted by the Clinical Trials Extramural Program. These 
discussions will reveal confidential trade secrets or commercial 
property such as patentable material, and personal information 
including consideration of personnel qualifications and performance, 
the competence of individual investigators and similar matters, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Information pertaining to the meeting may be obtained from Dr. John 
S. Cole, III, Executive Secretary, National Cancer Institute Clinical 
Trials Review Working Group, National Cancer Institute, 6130 Executive 
Blvd., EPN, Rm. 540, Bethesda, MD 20892 (301-496-1718).
    Individuals who plan to attend and need special assistance such as 
sign language interpretation or other reasonable accommodations should 
contact Dr. Cole in advance of the meeting.

    Dated: October 28, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-28266 Filed 11-1-96; 8:45 am]
BILLING CODE 4101-01-M